BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7021675)

  • 1. A serum C3-activating factor: its characterization and its presence in glomerular deposits.
    Roberts JL; Levy M; Chioros PG; Bartlow BG; Forristal J; West CD; Habib R; Lewis EJ
    J Immunol; 1981 Sep; 127(3):1131-7. PubMed ID: 7021675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation by circulating serum factors in human glomerulonephritis.
    Meri S
    Clin Exp Immunol; 1985 Feb; 59(2):276-84. PubMed ID: 3919977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
    Ruley EJ; Forristal J; Davis NC; Andres C; West CD
    J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular complement components in human glomerulonephritis.
    Verroust PJ; Wilson CB; Cooper NR; Edgington TS; Dixon FJ
    J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy.
    Rahman MA; Liu CN; Dunn MJ; Emancipator SN
    Lab Invest; 1988 Oct; 59(4):477-83. PubMed ID: 3050273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice.
    Fornasieri A; Li M; Armelloni S; de Septis CP; Schiaffino E; Sinico RA; Schmid C; D'Amico G
    Lab Invest; 1993 Nov; 69(5):531-40. PubMed ID: 8246445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse podocyte complement factor H: the functional analog to human complement receptor 1.
    Alexander JJ; Wang Y; Chang A; Jacob A; Minto AW; Karmegam M; Haas M; Quigg RJ
    J Am Soc Nephrol; 2007 Apr; 18(4):1157-66. PubMed ID: 17344423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranoproliferative glomerulonephritis with isolated C3 deposits: case report and literature review.
    Darouich S; Goucha R; Jaafoura MH; Zekri S; Kheder A; Ben Maiz H
    Ultrastruct Pathol; 2011 Feb; 35(1):42-6. PubMed ID: 21265634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
    Servais A; Noël LH; Dragon-Durey MA; Gübler MC; Rémy P; Buob D; Cordonnier C; Makdassi R; Jaber W; Boulanger E; Lesavre P; Frémeaux-Bacchi V
    Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).
    Jansen JH; Høgåsen K; Mollnes TE
    Am J Pathol; 1993 Nov; 143(5):1356-65. PubMed ID: 8238252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for glomerular modulation of complement activation.
    Moseley HL; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):9-13. PubMed ID: 95813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and identification of the third component of complement of Japanese quails.
    Kai C; Yoshikawa Y; Yamanouchi K; Okada H
    J Immunol; 1983 Jun; 130(6):2814-20. PubMed ID: 6343485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.